Hui Ou Yang
Oprichter bij MingMed Biotechnology Co., Ltd.
Actieve functies van Hui Ou Yang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Oprichter | 25-11-2019 | - |
| Hoofd Techniek/Wetenschap/O&O | 19-12-2019 | - | |
| Directeur/Bestuurslid | 25-11-2019 | 27-07-2022 |
Loopbaan van Hui Ou Yang
Opleiding van Hui Ou Yang
| Peking University Health Science Center | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Statistieken
Internationaal
| China | 3 |
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Beurs
- Insiders
- Hui Ou Yang
- Ervaring
